← Browse by Condition
Medical Condition

b7 h3 positive relapsed refractory neuroblastoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05562024 Phase 1
Recruiting

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

Enrollment
24 pts
Location
China
Sponsor
PersonGen BioTherapeutics (Suz...
View Trial →